Literature DB >> 17360740

Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage.

Hsuen-Chin Chen1, Florence M Hofman, John T Kung, Yang-Ding Lin, Betty A Wu-Hsieh.   

Abstract

Hemorrhage is a common clinical manifestation in dengue patients. However, the pathogenic mechanism of dengue virus (DV)-induced hemorrhage awaits clarification. We established a mouse model of DV hemorrhage using immunocompetent C57BL/6 mice by injecting DV serotype 2 strain 16681 intradermally. While inoculation of 3 x 10(9) PFU of DV induced systemic hemorrhage in all of the mice by day 3 of infection, one out of three of those injected with 4 x 10(7) to 8 x 10(7) PFU developed hemorrhage in the subcutaneous tissues. The mice that were inoculated with 4 x 10(7) to 8 x 10(7) PFU but that did not develop hemorrhage were used as a basis for comparison to explore the pathogenic mechanism of dengue hemorrhage. The results showed that mice with severe thrombocytopenia manifested signs of vascular leakage and hemorrhage. We observed that high viral titer, macrophage infiltration, and tumor necrosis factor alpha (TNF-alpha) production in the local tissues are three important events that lead to hemorrhage. Immunofluorescence staining revealed that DV targeted both endothelial cells and macrophages. In addition, the production of high levels of TNF-alpha in tissues correlated with endothelial cell apoptosis and hemorrhage. By comparing TNF-alpha(-/-) to IgH(-/-), C5(-/-), and wild-type mice, we found that TNF-alpha was important for the development of hemorrhage. In vitro studies showed that mouse primary microvascular endothelial cells were susceptible to DV but that TNF-alpha enhanced DV-induced apoptosis. Our mouse model illustrated that intradermal inoculation of high titers of DV predisposes endothelial cells to be susceptible to TNF-alpha-induced cell death, which leads to endothelium damage and hemorrhage development. This finding highlights the contribution of the innate immune response to dengue hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360740      PMCID: PMC1900309          DOI: 10.1128/JVI.02575-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Complement pathway activity in serum from patients with classical dengue fever.

Authors:  M F Shaio; F Y Chang; S C Hou
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Nov-Dec       Impact factor: 2.184

2.  Molecular evolution and distribution of dengue viruses type 1 and 2 in nature.

Authors:  R Rico-Hesse
Journal:  Virology       Date:  1990-02       Impact factor: 3.616

Review 3.  The pathophysiology of tumor necrosis factors.

Authors:  P Vassalli
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

4.  Endothelial cells. Not just a cellophane wrapper.

Authors:  L Kaiser; H V Sparks
Journal:  Arch Intern Med       Date:  1987-03

5.  High levels of sTNFR p75 and TNF alpha in dengue-infected patients.

Authors:  D Hober; A S Delannoy; S Benyoucef; D De Groote; P Wattré
Journal:  Microbiol Immunol       Date:  1996       Impact factor: 1.955

6.  Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients.

Authors:  D Hober; L Poli; B Roblin; P Gestas; E Chungue; G Granic; P Imbert; J L Pecarere; R Vergez-Pascal; P Wattre
Journal:  Am J Trop Med Hyg       Date:  1993-03       Impact factor: 2.345

7.  Complement and dengue haemorrhagic fever/shock syndrome.

Authors:  P Malasit
Journal:  Southeast Asian J Trop Med Public Health       Date:  1987-09       Impact factor: 0.267

8.  Dengue haemorrhagic fever and dengue shock syndrome: are they tumour necrosis factor-mediated disorders?

Authors:  M Yadav; K R Kamath; N Iyngkaran; M Sinniah
Journal:  FEMS Microbiol Immunol       Date:  1991-12

9.  Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection.

Authors:  S J Wu; C G Hayes; D R Dubois; M G Windheuser; Y H Kang; D M Watts; D G Sieckmann
Journal:  Am J Trop Med Hyg       Date:  1995-05       Impact factor: 2.345

10.  Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development.

Authors:  H S Baldwin; H M Shen; H C Yan; H M DeLisser; A Chung; C Mickanin; T Trask; N E Kirschbaum; P J Newman; S M Albelda
Journal:  Development       Date:  1994-09       Impact factor: 6.868

View more
  79 in total

Review 1.  Mosquito vectors and the spread of cancer: an overlooked connection?

Authors:  Giovanni Benelli; Annalisa Lo Iacono; Angelo Canale; Heinz Mehlhorn
Journal:  Parasitol Res       Date:  2016-04-07       Impact factor: 2.289

Review 2.  Endothelial cells in dengue hemorrhagic fever.

Authors:  Anon Srikiatkhachorn; James F Kelley
Journal:  Antiviral Res       Date:  2014-07-12       Impact factor: 5.970

Review 3.  Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms.

Authors:  Alan L Rothman
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

4.  Evaluation of cytokines as Th1/Th2 markers in pathogenesis of children with Crimean-Congo hemorrhagic fever.

Authors:  Enver Sancakdar; Ahmet Sami Güven; Elif Bilge Uysal; Ali Kaya; Köksal Deveci; Hekim Karapınar; Ismail Akkar
Journal:  Int J Clin Exp Med       Date:  2014-03-15

Review 5.  Recent advances in research on Crimean-Congo hemorrhagic fever.

Authors:  Anna Papa; Ali Mirazimi; Iftihar Köksal; Augustin Estrada-Pena; Heinz Feldmann
Journal:  J Clin Virol       Date:  2014-10-22       Impact factor: 3.168

6.  Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production.

Authors:  Sandesh Subramanya; Sang-Soo Kim; Sojan Abraham; Jiahong Yao; Mukesh Kumar; Priti Kumar; Viraga Haridas; Sang-Kyung Lee; Leonard D Shultz; Dale Greiner; Manjunath N; Premlata Shankar
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

Review 7.  Plasma leakage in dengue haemorrhagic fever.

Authors:  Anon Srikiatkhachorn
Journal:  Thromb Haemost       Date:  2009-12       Impact factor: 5.249

8.  A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice.

Authors:  Grace K Tan; Jowin K W Ng; Scott L Trasti; Wouter Schul; George Yip; Sylvie Alonso
Journal:  PLoS Negl Trop Dis       Date:  2010-04-27

9.  Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification.

Authors:  Scott J Balsitis; Katherine L Williams; Ruben Lachica; Diana Flores; Jennifer L Kyle; Erin Mehlhop; Syd Johnson; Michael S Diamond; P Robert Beatty; Eva Harris
Journal:  PLoS Pathog       Date:  2010-02-12       Impact factor: 6.823

10.  Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice.

Authors:  Smita Jaiswal; Todd Pearson; Heather Friberg; Leonard D Shultz; Dale L Greiner; Alan L Rothman; Anuja Mathew
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.